Frailty Increase Rectal Prolapse Recurrence

November 13, 2025 updated by: Tamer.A.A.M.Habeeb, Zagazig University

Rectal Prolapse and Recurrent RP

evaluate recurrent RP in relation to frailty

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

342

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

elderly patients with RP

Description

Inclusion Criteria:

  • EPs aged ≥60 years EFTRP (Oxford prolapse grade 5)

Exclusion Criteria:

  • • aged < 60 years

    • incomplete medical records,
    • concurrent colorectal procedures,
    • multi-compartmental prolapse requiring combined operations,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
laparoscopic ventral rectopexy
LVMR for management of rectal prolapse
LVMR for management of RP
perineal stapler resection
PSR for management of RP
PSR for management of RP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
recurrence in relation to frailty
Time Frame: 5 years
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tamer.A.A.M. Habeeb, Zagazig University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2014

Primary Completion (Actual)

October 1, 2020

Study Completion (Actual)

October 1, 2025

Study Registration Dates

First Submitted

November 13, 2025

First Submitted That Met QC Criteria

November 13, 2025

First Posted (Actual)

November 17, 2025

Study Record Updates

Last Update Posted (Actual)

November 17, 2025

Last Update Submitted That Met QC Criteria

November 13, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rectal Prolapse

Clinical Trials on LVMR for RP

Subscribe